This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Covetrus Dividends and Buybacks

Dividend criteria checks 0/6

Key information

n/a

Dividend yield

-0.03%

Buyback Yield

Total Shareholder Yield	-0.03%
Future Dividend Yield	0%
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line

Aug 04

Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders

Jun 02

Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

May 02

Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

Jan 07

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Oct 21

An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

Sep 16

Covetrus (NASDAQ:CVET) Shareholders Have Enjoyed An Impressive 106% Share Price Gain

Dec 18

Covetrus, Inc. 2020 Q3 - Results - Earnings Call Presentation

Nov 12

Covetrus Q3 2020 Earnings Preview

Nov 09

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if CVET's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CVET's dividend payments have been increasing.

Dividend Yield vs Market

Covetrus Dividend Yield vs Market

How does CVET dividend yield compare to the market?
Segment	Dividend Yield
Company (CVET)	n/a
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.5%
Industry Average (Healthcare)	1.9%
Analyst forecast (CVET) (up to 3 years)	0%

Notable Dividend: Unable to evaluate CVET's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CVET's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as CVET has not reported any payouts.

Discover strong dividend paying companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/10/16 02:46
End of Day Share Price	2022/10/12 00:00
Earnings	2022/06/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Covetrus, Inc. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	Argus Research Company
Robert Eich	Cleveland Research Company
Erin Wilson Wright	Credit Suisse

This company has been acquired

Covetrus Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

Covetrus, Inc. Files Form 15

Covetrus, Inc.(NasdaqGS:CVET) dropped from NASDAQ Composite Index

Covetrus Announces the Appointment of Michelle Bonfilio as Chief People Officer

Insider exercised options and sold US$185k worth of stock

Covetrus Appoints Margie B. Pritchard as General Counsel and Corporate Secretary

President notifies of intention to sell stock

Covetrus, Inc. Announces Retirement of Matthew Foulston as Executive Vice President, Effective December 31, 2022

Saxena White P.A. Announces Settlement of Class Action on Behalf of Purchasers of Covetrus, Inc. Common Stock

Second quarter 2022 earnings: EPS misses analyst expectations

Covetrus GAAP EPS of -$0.03 misses by $0.06, revenue of $1.22B in-line

Covetrus, Inc. to Report Q2, 2022 Results on Aug 04, 2022

President exercised options and sold US$196k worth of stock

President notifies of intention to sell stock

Key Executive exercised options and sold US$162k worth of stock

Independent Director recently sold US$709k worth of stock

President notifies of intention to sell stock

Executive VP & Global CFO exercised options and sold US$259k worth of stock

Clayton, Dubilier & Rice/TPG Are Not Offering Fair Value To Covetrus Shareholders

Price target increased to US$23.00

Clayton, Dubilier & Rice, LLC and TPG Global, LLC offered to acquire remaining 75.8% stake in Covetrus, Inc. (NasdaqGS:CVET) $2.2 billion.

Price target decreased to US$21.40

First quarter 2022 earnings: EPS misses analyst expectations

Covetrus® Introduces Innovative Cloud-Based Practice Management Software for Veterinarians in the United Kingdom, EMEA and Asia Pacific

Covetrus, Inc.'s (NASDAQ:CVET) Intrinsic Value Is Potentially 98% Above Its Share Price

Covetrus, Inc. to Report Q1, 2022 Results on May 05, 2022

President exercised options and sold US$149k worth of stock

Covetrus, Inc., Annual General Meeting, May 11, 2022

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations

Covetrus, Inc. to Report Q4, 2021 Results on Feb 24, 2022

CEO, President & Director exercised options and sold US$111k worth of stock

Chief Administrative Officer exercised options and sold US$121k worth of stock

Covetrus, Inc. Announces the Launch of Covetrus Pulse

Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 40%?

CEO, President & Director notifies of intention to sell stock

Price target decreased to US$28.60

Third quarter 2021 earnings released: US$0.029 loss per share (vs US$0.34 loss in 3Q 2020)

CEO, President & Director exercised options and sold US$193k worth of stock

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Chief Administrative Officer exercised options and sold US$229k worth of stock

An Intrinsic Calculation For Covetrus, Inc. (NASDAQ:CVET) Suggests It's 37% Undervalued

VP, Chief Accounting Officer & Global Controller Laura Phillips has left the company

Director recently bought US$116k worth of stock

Price target decreased to US$31.33

Second quarter 2021 earnings released: US$0.23 loss per share (vs US$0.41 profit in 2Q 2020)

Covetrus, Inc. (NasdaqGS:CVET) entered into a definitive agreement to acquire VCP.

CEO, President & Director notifies of intention to sell stock

Covetrus Enhances to Their Practice Management Software to Help Veterinary Clinics Compete Online and Deliver More Complete Healthcare

Estimating The Intrinsic Value Of Covetrus, Inc. (NASDAQ:CVET)

CEO, President & Director notifies of intention to sell stock

First quarter 2021 earnings released: US$0.12 loss per share (vs US$0.26 loss in 1Q 2020)

Covetrus, Inc. 2021 Q1 - Results - Earnings Call Presentation

Is Covetrus (NASDAQ:CVET) Using Too Much Debt?

Covetrus, Inc.: Well Positioned To Enjoy Market Crosscurrents

CEO, President & Director exercised options and sold US$277k worth of stock

CEO, President & Director notifies of intention to sell stock

Independent Director recently sold US$203k worth of stock

Covetrus, Inc. Announces the Addition of Stacey M.M. Shirra as Vice President of Global Talent Management

Insider exercised options and sold US$59k worth of stock

Full year 2020 earnings released: US$0.16 loss per share (vs US$9.52 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Who Has Been Selling Covetrus, Inc. (NASDAQ:CVET) Shares?

Covetrus Appoints Link Welborn as Chief Veterinary Officer

Covetrus, Inc. to Report Q4, 2020 Results on Mar 01, 2021

Covetrus Appoints Deborah Sharkey as Chief Consumer Officer

New 90-day high: US$39.89

Chief Administrative Officer notifies of intention to sell stock

Covetrus, Inc.(NasdaqGS:CVET) dropped from Russell 1000 Growth-Defensive Index

We Think Covetrus (NASDAQ:CVET) Has A Fair Chunk Of Debt

Chief Administrative Officer notifies of intention to sell stock

Covetrus reports Q4 net sales of prescription management business

Price target raised to US$29.00

New 90-day high: US$32.55

Chief Administrative Officer notifies of intention to sell stock